You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

H3F3AK27M

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

H3 K27M, Glioma Trial in Santa Monica (ONC201, ONC201 + Placebo, Placebo)

Recruiting
  • H3 K27M
  • Glioma
  • Santa Monica, California
    Providence Saint John's Cancer Institute
Nov 28, 2022

Diffuse Midline Glioma, H3 K27M-Mutant Trial in San Francisco (Cyclophosphamide, Fludarabine, Autologous Anti-H3.3K27M

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • San Francisco, California
    University of California, San Francisco
Aug 15, 2022

Diffuse Intrinsic Pontine Glioma Trial in Beijing (Histone H3.3-K27M Neoantigen Vaccine Therapy)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Histone H3.3-K27M Neoantigen Vaccine Therapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Jul 18, 2022

CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

Not yet recruiting
  • Central Nervous System Neoplasms
  • +6 more
  • B7-H3-CAR T cells
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Apr 18, 2023

Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Glioma Trial (Re-irradiation)

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • +5 more
  • Re-irradiation
  • (no location specified)
Oct 16, 2023

Glioblastoma, Diffuse Midline Glioma, H3 K27M Glioma Trial in United States (ONC201)

Active, not recruiting
  • Glioblastoma
  • +5 more
  • Los Angeles, California
  • +4 more
Apr 8, 2022

Glioma Trial in Philadelphia (ONC201)

No longer available
  • Glioma
  • Philadelphia, Pennsylvania
    Oncoceutics
Mar 10, 2022

Diffuse Midline Glioma, H3 K27M-Mutant Trial (GD2 CAR T cells)

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • GD2 CAR T cells
  • (no location specified)
Sep 15, 2022

Diffuse Midline Glioma, H3 K27M-Mutant Trial in Rochester (Hypofractionated Radiation Therapy, Quality-of-Life Assessment,

Recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • Hypofractionated Radiation Therapy
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Newly Diagnosed H3-mutated Glioma Trial in Germany (drug, biological, other)

Recruiting
  • Newly Diagnosed H3-mutated Glioma
  • Tecentriq 1200 MG in 20 ML Injection
  • +2 more
  • Mannheim, Baden-Wuerttemberg, Germany
  • +7 more
Jan 18, 2023

Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)

Not yet recruiting
  • Bipolar Disorder
  • Calgary, Alberta, Canada
  • +7 more
May 18, 2023

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in New York (Etoposide; Oral, 50 Mg, Focused

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • Etoposide; Oral, 50 Mg
  • Focused ultrasound with neuro-navigator-controlled sonication
  • New York, New York
    Columbia University Irving Medical Center
Feb 28, 2023

Glioblastoma Trial in Rochester (radiation, procedure, drug, other)

Recruiting
  • Glioblastoma
  • Accelerated Hypofractionated Radiation Therapy
  • +8 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Mar 24, 2023

Children After Hospitalization in Intensive Care Unit

Not yet recruiting
  • Renal Disease
  • +7 more
  • neurocognitive tests
  • Calgary, Alberta, Canada
  • +7 more
Nov 3, 2023

Recurrent Osteosarcoma Trial in Los Angeles, New York, Houston (humanized anti-GD2 antibody, GM-CSF)

Recruiting
  • Recurrent Osteosarcoma
  • humanized anti-GD2 antibody
  • GM-CSF
  • Los Angeles, California
  • +2 more
Dec 22, 2022

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Villejuif (Everolimus, ONC201, Radiotherapy)

Not yet recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jul 27, 2022

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

Not yet recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 23, 2023

Glioma, H3 K27M Trial in United States (ONC201)

Available
  • Glioma
  • H3 K27M
  • Phoenix, Arizona
  • +21 more
Sep 23, 2022

Oral Upadacitinib Tablets to Assess Change in Disease Symptoms

Recruiting
  • Rheumatoid Arthritis (RA)
    • Edmonton, Alberta, Canada
    • +38 more
    Jan 17, 2023

    Brain Cancer Trial in Salt Lake City ([18F]fluoro-2-deoxy-D-glucose (FDG),

    Recruiting
    • Brain Cancer
    • [18F]fluoro-2-deoxy-D-glucose (FDG)
    • +3 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Jan 3, 2023

    Brodalumab in Plaque Psoriasis to Understand Impact on Quality

    Recruiting
    • Psoriasis
    • Brodalumab
    • Matched cohort
    • Calgary, Alberta, Canada
    • +33 more
    Oct 8, 2022

    High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)

    Not yet recruiting
    • High Grade Glioma
    • +8 more
    • Aurora, Colorado
    • +17 more
    May 2, 2023

    Diffuse Intrinsic Pontine Glioma, Glioma, Malignant Trial in United States (ONC201)

    Recruiting
    • Diffuse Intrinsic Pontine Glioma
    • Glioma, Malignant
    • San Francisco, California
    • +7 more
    Mar 1, 2022

    Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Ipilimumab)

    Terminated
    Has Results
    • Renal Cell Carcinoma
    • Nivolumab
    • Ipilimumab
    • Saint Louis, Missouri
    • +11 more
    Dec 15, 2022

    B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

    Not yet recruiting
    • B Acute Lymphoblastic Leukemia
    • Biospecimen Collection
    • +19 more
    • (no location specified)
    Nov 8, 2023